Novo Nordisk Total Non-Operating Income/Expense 2012-2026 | NVO
Novo Nordisk total non-operating income/expense for the twelve months ending March 31, 2026 was $1.084B, a 355.14% decline year-over-year.
- Novo Nordisk annual total non-operating income/expense for 2025 was $0.436B, a 362.13% decline from 2024.
- Novo Nordisk annual total non-operating income/expense for 2024 was $-0.166B, a 154.59% decline from 2023.
- Novo Nordisk annual total non-operating income/expense for 2023 was $0.305B, a 137.47% decline from 2022.